Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

The Ministry of Public Health and the Lebanese Pediatric Society urge parents to get their Children Vaccinated against Measles

 
WHO and UNICEF call for collective actions to fight measles during outbreak
 
 
February 17, 2020 – The recent measles vaccination campaign launched back in December following the outbreak that has spread across Lebanon have many parents concerned. The Ministry of Public Health, along with the Lebanese Pediatric Society, WHO and UNICEF are very concerned about certain misconstrued comments expressed over the last few weeks by parents on social media and WhatsApp messages. These comments are found to be wrong and misleading, while the only way to protect the child against measles is the vaccination.
 
Since onset in early 2018, the measles outbreak has spread to all eight Lebanese governorates, counting more than 2,000 reported cases, most prominently among children less than 10 years of age.
 
“Choosing to not vaccinate your children during the campaign not only leaves them susceptible to measles, but also exposes other children to measles,” said Dr. Walid Amar, Director General of the Ministry of Public Health. “The Ministry of Public Health, with the support of the World Health Organization and UNICEF, provides safe and effective vaccines free of charge to children through trained teams of health workers in all institutions. We urge all parents to take advice from health professionals on health issues because health policies and practices are evidenced based and not based on rumors”.
 
Measles is a serious and highly contagious disease. If not prevented, measles can cause serious complications including meningitis, severe diarrhea and dehydration, pneumonia and ear infections and even death. Measles survivors are often left with life-long disabilities, such as blindness, deafness and brain damage.
 
“It is important to vaccinate your children during the campaign. The third additional dose of the measles containing vaccine is crucial for optimal immunity and it is safe,” explained Dr. Bizri, Head of National Certification Committee (NCC).  “The cold chain at the MoPH Central Drugs Warehouse and the primary health care facilities are of optimal quality and ensure safe storage of vaccines. Finally, it is important to note that MoPH provides free vaccines to some major private sector health facilities”.
 
“The measles vaccine is safe and effective.  A child to be better protected needs to receive at least two doses of Measles, and there is no harm in receiving an additional dose. There are no reasons children should still be dying of this disease,” added Dr. Majdalani, Head of Lebanese pediatric society.
 
“Immunizations can save a child’s life and vaccines are only given to children after a long and careful review by scientists, doctors, and healthcare professionals. The only way to halt the epidemic currently is to vaccinate all children, between the age of 6 months and 10 years. The Measles vaccine protects children against avoidable lifelong complications and potentially death. No child should be left behind” said Dr Shankiti, representative of WHO office in Lebanon
 
The measles vaccine is procured by UNICEF through its Global Supply Division who is responsible for buying all vaccines and related items for global campaigns to eradicate polio, eliminate neonatal and maternal tetanus, and control measles. All vaccines procured through UNICEF are WHO pre-qualified and follow strict safety standards and quality control. WHO and UNICEF promote vaccine security by working with manufacturers to ensure there is a reliable supply of quality, affordable vaccines, and with governments to assess their vaccine requirements.
 
“UNICEF has a key role in vaccine procurement and procuring immunization supplies on behalf of around 100 countries annually,” said Yukie Mokuo, UNICEF representative in Lebanon. “For the past 25 years UNICEF has brought quality vaccine to the Ministry of Public health to vaccinate all children in Lebanon. Parents and communities are urged to take part in the upcoming measles vaccination campaign to reach every child.”
 
WHO and UNICEF are working with the ministry of Public Health to support vaccine supply and cold chain management, on-the-ground coordination, operations support and monitoring. WHO and UNICEF are also working with the MOPH to ensure clear communication to mobilize the general public aiming to achieve high turnout of all children under 10 years old for vaccination.
 
Representatives from the Ministry of Public Health, WHO, UNICEF, the Lebanese Pediatric Society regional delagates and the heads of other medical societies, stressed during the meeting on the need for commitment and active participation in the campaign, and the need to urge parents and advise them to give their children the extra dose during the campaign regardless of previous doses and that the vaccines provided by the Ministry of Public Health are safe and effective and that the cold chain in its central warehouse and in primary health care centers are of ideal quality and are subject to safe storage conditions .
 
The second phase of the national immunization campaign will be launched in April 2020 targeting children aged between 6 months to less than 10 years old.  All children will also receive vaccination with bivalent Oral Polio Vaccine. Children will be reached in primary healthcare centers/dispensaries, schools, nurseries and private clinics, as well as in Informal settlements
 
ENDS
 
 
About WHO

WHO is the directing and coordinating authority for health within the United Nations. Our aim is to improve future health prospects for people everywhere. WHO works in coordination with its 194 Member States in six regions, through more than 150 country offices, with a single-minded commitment to improve universal health. Together, we aspire to fight communicable diseases such as influenza or HIV, and noncommunicable diseases such as cancer or heart disease. We help mothers and children to survive and prosper, so that they have every chance of reaching a healthy old age. We monitor the safety of air, food and water, and of medicines and vaccines too. Learn more about us at www.who.int
 
About UNICEF

UNICEF works in some of the world’s toughest places, to reach the world’s most disadvantaged children. Across more than 190 countries and territories, we work for every child, everywhere, to build a better world for everyone. For more information about UNICEF and our work in Lebanon visit https://www.unicef.org/lebanon/
 
Follow UNICEF Lebanon on Twitter, Facebook, Instagram and Youtube
 
 
For more information, please contact:

Ministry of Public Health
Dr. Randa Hamade, randa_ham@hotmail.com , T: +961 3 538 878
 
UNICEF
Blanche Baz, bbaz@unicef.org T. +961 03331874
 
WHO
Hala Habib, hhabib@who.int , T: +961 3870459
 
    ...
    7
    ...
ATC Name B/G Ingredients Dosage Form Price
A07DA03 IMODIUM B Loperamide HCl - 2mg 2mg Capsule 138,416 L.L
L01EL01 IMBRUVICA B Ibrutinib - 420mg 420mg Tablet, film coated 562,026,556 L.L
L04AA29 XELJANZ XR B Tofacitinib - 11mg 11mg Tablet, extended release 78,687,316 L.L
N02BE01 DOLIPRANE B Paracetamol - 1,000mg 1000mg Tablet 120,946 L.L
N04BC09 NEUPRO B Rotigotine - 8mg/24h 8mg/24h Patch 12,394,936 L.L
R03AK08 INUVER B Formoterol fumarate - 6mcg/dose, Beclometasone dipropionate - 100mcg/dose Inhalation solution 3,493,991 L.L
S01AA23 NETTACIN B Netilmicin - 0.3% 0.3% Drops solution 681,328 L.L
L01EL02 CALQUENCE B Acalabrutinib - 100mg 100mg Capsule 650,653,454 L.L
N02BE01 DOLIPRANE B Paracetamol - 1000mg 1000mg Tablet 120,946 L.L
N06AX16 EFEXOR XR B Venlafaxine (HCl) - 150mg 150mg Capsule, sustained release 817,056 L.L
R03AK08 INUVER NEXTHALER B Formoterol fumarate dihydrate - 6mcg/dose, Beclometasone dipropionate - 100mcg/dose Inhalation powder 4,380,927 L.L
S01AA23 NETTACIN B Netilmicin - 0.3% 0.3% Ointment 593,978 L.L
L01XG02 KYPROLIS B Carfilzomib - 60mg 60mg Injectable powder for solution L.L
A07DA03 IMODIUM INSTANTS B Loperamide HCl - 2mg 2mg Tablet, orodispersible 451,531 L.L
A10BJ06 OZEMPIC B Semaglutide - 0.25mg 0.25mg Injectable solution 10,927,526 L.L
C03CA01 LASIX B Furosemide - 500mg 500mg Tablet 1,454,038 L.L
J07BK01 VARILRIX + SOLVENT IN SYRINGE B Varicella virus, live attenuated - ?1033 PFU ?1033 PFU Injectable lyophilised powder for solution+diluent 3,473,833 L.L
L01EM03 PIQRAY B Alpelisib - 150mg 150mg Tablet, film coated 359,195,954 L.L
L04AA31 AUBAGIO B Teriflunomide - 14mg 14mg Tablet, film coated 38,773,533 L.L
N02BE01 EFFERALGAN B Paracetamol - 1g 1g Tablet, film coated 129,009 L.L
R03AK10 RELVAR ELLIPTA B Vilanterol (trifenatate) - 25mcg/dose, Fluticasone furoate - 200mcg/dose Inhalation powder 3,928,052 L.L
L01EX09 OFEV B Nintedanib - 150mg 150mg Capsule, soft L.L
A10BJ06 OZEMPIC B Semaglutide - 0.5mg 0.5mg Injectable solution 10,927,526 L.L
B02BC30-V03AK TISSEEL LYO B Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml Injectable powder for solution + solution 53,437,592 L.L
C03CA02 BURINEX B Bumetanide - 1mg 1mg Tablet 335,961 L.L
J07BK01 VARIVAX B Varicella virus, live attenuated - 1350PFU Injectable powder for suspension+diluent 4,102,751 L.L
L01EM03 PIQRAY B Alpelisib - 200mg, Alpelisib - 50mg 150mg Tablet, film coated 359,195,954 L.L
L04AA31 AUBAGIO B Teriflunomide - 14mg 14mg Tablet, film coated 38,773,533 L.L
R03AK10 RELVAR ELLIPTA B Vilanterol (trifenatate) - 25mcg/dose, Fluticasone furoate - 100mcg/dose Inhalation powder 3,928,052 L.L
S01AD09 VIRGAN B Ganciclovir - 1.5mg/g 1.5mg/g Gel 804,962 L.L
    ...
    7
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025